Plasma IGF-1 and IGFBP-3 may be imprecise surrogates for breast concentrations: an analysis of healthy women.

We investigated insulin-like growth factor (IGF)-1 and IGF binding protein (IGFBP)-3 concentrations in histologically normal breast tissues and assessed their association with plasma concentrations, and breast cancer risk factors. IGF-1 and IGFBP-3 were assessed in plasma and breast tissues of 90 women with no history of any cancer and undergoing reduction mammoplasty. Pearson correlations and ANOVAs were used to describe plasma-breast associations and biomarker differences by breast cancer risk factors, respectively. Multivariable regression models were used to determine associations between risk factors, and breast IGF-1 and IGFBP-3. The mean age of the study sample was 37.3 years, 58 % were white, and generally these women were obese (mean BMI = 30.8 kg/m(2)). We observed no plasma-breast correlation for IGF-1, IGFBP-3, or IGF-1/IGFBP-3 (r = -0.08, r = 0.14, and r = 0.03, respectively; p-values >0.05). Through age- and BMI-adjusted analysis, BMI and years of oral contraceptive (OC) use were inversely associated with breast IGF-1 (p-values = 0.02 and 0.003, respectively) and age was associated with breast IGFBP-3 (p = 0.01), while breast IGF-1/IGFBP-3 was higher in blacks than whites (1.08 vs. 0.68, p = 0.04) and associated with age and BMI (p-values = 0.03 and 0.002, respectively). In multivariable-adjusted models, some breast cancer risk factors studied herein explained 24, 10, and 15 % of the variation in breast IGF-1, IGFBP-3, and IGF-1/IGFBP-3, respectively. While reasons for the lack of plasma-breast hormone correlations in these cancer-free women are unknown, several factors were shown to be associated with breast concentrations. The lack of correlation between blood and tissue IGF-1 and IGFBP-3 suggests that studies of breast cancer risk assessing blood IGF-1 and IGFBP-3 may have important limitations in understanding their role in breast carcinogenesis.

Adipokines in plasma and breast tissues: associations with breast cancer risk factors.

BACKGROUND: Blood adipokines are associated with breast cancer risk; however, blood-breast adipokine correlations and factors that explain variation in adipokines are unknown. METHODS: Plasma (n = 155) and breast (n = 85) leptin and adiponectin were assessed by immunoassays in women with no history of cancer. Multivariable-adjusted regression models were used to determine breast adipokine associations. RESULTS: Through body mass index (BMI)-adjusted analyses, we initially observed positive plasma-breast correlations for leptin (r = 0.41, P = 0.0002) and adiponectin (r = 0.23, P = 0.05). The positive plasma-breast correlation for leptin was strongest among normal weight women (r = 0.62), whereas the correlation for adiponectin was strongest among obese women (r = 0.31). In multivariable models, adjusting for BMI, demographic, reproductive, and lifestyle factors, plasma leptin was not associated with breast leptin, and only the highest quartile of plasma adiponectin was associated with tissue levels. Of the risk factors investigated, those that contributed most to the variation in breast tissue adipokines were BMI and race for leptin, oral contraceptive use and smoking status for adiponectin. CONCLUSIONS: Although we report positive plasma-breast adipokine correlations overall, plasma adipokine concentrations may not be good surrogates for breast concentrations among all women. Predictors of breast adipokines vary, depending on subject characteristics, possibly explaining inconsistent epidemiologic results and they implicate differing pathways toward carcinogenesis. IMPACT: A clearer understanding of the relationships between plasma adipokines and their levels within the target organ is necessary to better understand the impact of these hormones on breast cancer risk. Future studies are needed to identify additional factors associated with breast adipokines in target tissues.

Teleassessment compared with live assessment of pressure ulcers in a wound clinic: a pilot study.

OBJECTIVE: To compare teleassessment of pressure ulcers in individuals with spinal cord injury in a simulated remote setting with in-person assessments in a wound clinic. DESIGN: Pressure ulcers were assessed using a 3-megapixel digital camera; images of each ulcer were forwarded to a laptop in a separate room. Nurses completed a medical history and wound database form. A plastic surgeon reviewed the images and database and completed a questionnaire concerning the "remote" teleassessment or teleconsultation. When needed, the plastic surgeon obtained additional information using live audio-video interaction with the participant or nurse. After the teleassessment was completed, the plastic surgeon then assessed the individual and wound live and completed the same questionnaire used for the teleassessment. SETTING: Wound clinic of a rehabilitation hospital. PARTICIPANTS: Individuals with a spinal cord injury and 1 or more pressure ulcers who were seen for initial or follow-up evaluations. MAIN OUTCOME MEASURES: Percentage of agreement for teleassessment versus live responses to 4 yes/no questions regarding the need to change wound management, satisfaction with teleassessment, need for referral, and need for additional information. MAIN RESULTS: Seventeen individuals with 20 wounds were evaluated. The total percentage of agreement for teleassessment versus live decisions was 89% (80% to 95%). The highest percentages of agreement were for the need to change wound management and the need for referral (both 95%); the lowest percentages of agreement were for satisfaction with teleassessment for making treatment decisions (85%) and the need to obtain additional information (80%). CONCLUSIONS: Teleassessment of pressure ulcers in individuals with a spinal cord injury using digital images and a standard database compared well with in-person assessment, which is similar to results reported for other pathologic conditions.